AT THE MARKET OFFERING AGREEMENT February 1, 2024At the Market Offering Agreement • February 1st, 2024 • Inhibikase Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Inhibikase Therapeutics, Inc., a corporation organized under the laws of Delaware (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (the “Manager”) as follows:
